Formulation And Evaluation Of Extended Release Capsules Of Antihypertensive Drug (Diltiazem Hydrochloride)
International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)
DOI: 10.25258/ijddt.16.28s.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von Vishal Sharma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Hypertension is a chronic cardiovascular disorder requiring continuous pharmacological management to prevent morbidity and mortality. Diltiazem hydrochloride, a non-dihydropyridine calcium channel blocker, is widely used in hypertension and angina but suffers from a short biological half-life and extensive first-pass metabolism, necessitating multiple daily dosing in conventional formulations. The present study aimed to formulate and evaluate extended-release (er) capsules of diltiazem hydrochloride using polymer-coated multiparticulate pellets to achieve sustained drug release and improved patient compliance. Pellets were prepared using suitable pelletization techniques and coated with rate-controlling polymers such as ethyl cellulose, hydroxypropyl methylcellulose (hpmc), and eudragit polymers. The optimized formulation demonstrated controlled drug release up to 20–24 hours following non-fickian diffusion kinetics. Pre- and post-formulation parameters confirmed excellent flow properties, uniform drug content, and reproducible dissolution profiles. The study concludes that pellet-based extended-release capsules of diltiazem hydrochloride provide a robust, stable, and patient-friendly dosage form for long-term antihypertensive therapy.
Zitieren
APA
Sharma, V., Tripathi, N., & Jain, V. (2026). Formulation And Evaluation Of Extended Release Capsules Of Antihypertensive Drug (Diltiazem Hydrochloride). International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.29
Vancouver
Sharma V, Tripathi N, Jain V. Formulation And Evaluation Of Extended Release Capsules Of Antihypertensive Drug (Diltiazem Hydrochloride). International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.29
BibTeX
@article{Sharma2026,
author = {Sharma, Vishal and Tripathi, Naveen and Jain, Vinay},
title = {Formulation And Evaluation Of Extended Release Capsules Of Antihypertensive Drug (Diltiazem Hydrochloride)},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {28s},
doi = {10.25258/ijddt.16.28s.29}
}
EUVIMED